Laboratory for Reproductive Immunology, Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China.
The Academy of Integrative Medicine of Fudan University, Shanghai, China.
Dis Markers. 2020 Oct 21;2020:8871951. doi: 10.1155/2020/8871951. eCollection 2020.
Antithyroid antibodies, which include thyroid-stimulating hormone receptor antibodies (TRAbs), thyroid peroxidase antibodies (TPOAbs), and thyroid globulin antibodies (TgAbs), are widely known for their tight association with thyroid autoimmune diseases. The variation in all three kinds of antibodies also showed different trends during and after pregnancy (Weetman, 2010). This article reviewed the the physiological changes, while focusing on the variation of thyroid antibodies concentration in women during and after pregnancy, and adverse consequences related to their elevation. Since abnormal elevations of these antithyroid antibodies may lead to adverse outcomes in both mothers and fetuses, special attention must be paid to the titer of the antibodies during pregnancy. The molecular mechanisms of the variations in those antibodies have yet to be explained. The frequency and timing of thyroid antibody measurement, as well as different reference levels, also remain to be elucidated.
抗甲状腺抗体,包括促甲状腺激素受体抗体(TRAbs)、甲状腺过氧化物酶抗体(TPOAbs)和甲状腺球蛋白抗体(TgAbs),因其与甲状腺自身免疫性疾病密切相关而广为人知。这三种抗体的变化在妊娠期间和之后也呈现出不同的趋势(Weetman,2010)。本文综述了这些变化,重点关注了妇女在妊娠期间和之后甲状腺抗体浓度的变化,以及与它们升高相关的不良后果。由于这些抗甲状腺抗体的异常升高可能导致母亲和胎儿的不良后果,因此在妊娠期间必须特别注意抗体的滴度。这些抗体变化的分子机制尚待解释。甲状腺抗体测量的频率和时间,以及不同的参考水平,也有待阐明。